文献速递新发突发、热带与寄生虫病

2024年马达加斯加恶性疟原虫kelch13基因多态性更新图谱

Updated mapping of Plasmodium falciparum kelch13 gene polymorphisms in Madagascar, 2024.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

2024年1至5月在马达加斯加开展全国代表性横断面调查,采集4850例发热患者血样,对1944份恶性疟原虫阳性样本行pfkelch13靶向扩增子深度测序。963份(49.5%)获序列,885份(91.9%)为3D7野生型,未检出WHO验证的青蒿素部分耐药标记。

要点

  • 马达加斯加未检出WHO验证的青蒿素部分耐药标记。
  • 963份序列中非 synonymous 突变占1.8%,同义突变占6.2%。
  • 最常见多态性为同义突变C469C(3.0%)和P417P(2.8%)。

核心结论

  • 马达加斯加采样地区未发现携带WHO验证青蒿素部分耐药标记的虫株,提示耐药虫株尚未建立。

研究设计与样本

  • 2024年1至5月全国代表性横断面调查,65家卫生机构4850例发热患者,采用靶向扩增子深度测序行pfkelch13基因分型。

主要发现

  • 1944份恶性疟原虫阳性样本中963份(49.5%)成功获得pfkelch13序列。
  • 885份(91.9%)为3D7野生型,非 synonymous 突变1.8%(17/963),同义突变6.2%(60/963),双重突变1例(0.1%)。
  • 18种突变中5种此前未报告,最常见为C469C(3.0%,29/963)和P417P(2.8%,27/963)。
  • 未检出任何WHO验证的青蒿素部分耐药标记。

临床怎么用

  • 结果为马达加斯加pfkelch13多态性提供更新基线,支持继续基因组监测以早期发现青蒿素部分耐药相关突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Artemisinin-resistant Plasmodium falciparum has emerged in several East African countries neighbouring Madagascar. Despite the island's substantial malaria burden, recent data on artemisinin partial resistance are limited, raising concerns about the potential emergence of resistant parasites. This study provides an updated overview of the prevalence and diversity of P. falciparum Kelch13 (pfkelch13) polymorphisms in Madagascar. METHODS: During a nationally representative, cross-sectional survey conducted between January and May 2024, dried blood samples were collected from 4850 febrile patients at 65 health facilities. Pfkelch13 genotyping was performed using a targeted amplicon deep sequencing approach. RESULTS: Of the 1944 P. falciparum-positive samples, 963 (49.5%) pfkelch13 sequences were successfully obtained, and 885 (91.9%) corresponded to the 3D7 wild-type. Non-synonymous and synonymous mutations were detected in 1.8% (17/963) and 6.2% (60/963) of isolates, respectively, whereas one isolate (0.1%) carried double mutations. Of the 18 mutations identified, 5 had not been previously reported. The two most frequent polymorphisms in Madagascar were the synonymous mutations C469C (3.0%, 29/963) and P417P (2.8%, 27/963). None of the WHO-validated artemisinin partial resistance markers were detected. CONCLUSION: This study provides an updated baseline of pfkelch13 polymorphisms in Madagascar, with no evidence of artemisinin partial resistance emergence. Importantly, no parasites harbouring a validated artemisinin resistance marker were detected across the regions sampled, suggesting that resistant parasites have not yet become established. These findings provide a valuable baseline for future genomic surveillance efforts aimed at the early detection of mutations associated with artemisinin partial resistance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Roesch C, Ratovoson R, Delaunay C, et al. Updated mapping of Plasmodium falciparum kelch13 gene polymorphisms in Madagascar, 2024. J Antimicrob Chemother. 2026. PMID: 42169509. doi:10.1093/jac/dkag181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。